Stockreport

Scholar Rock Announces Publication in Science Translational Medicine of Preclinical Data Detailing a Potent and Selective Inhibitor of TGFß1 Overcoming Primary Resistance to Checkpoint Inh...

Scholar Rock Holding Corporation  (SRRK) 
Last scholar rock holding corporation earnings: 11/12 07:30 am Check Earnings Report
PDF - Retrospective analyses of clinical tumor samples identify TGFß1 as the most prevalent TGFß isoform in most solid cancers- Preclinical results demonstrate highly select [Read more]